Serological assays for delayed SARS-CoV-2 case identification - Author's reply

Comment

. 2020 Oct;8(10):e74.

doi: 10.1016/S2213-2600(20)30406-9. Epub 2020 Sep 14.

Affiliations

¹ Centre of Defence Pathology, Royal Centre for Defence Medicine, Queen Elizabeth Hospital Birmingham, Birmingham B15 2WB, UK; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK. Electronic address: scott.pallett@nhs.net.
² Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
³ NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
⁴ Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; North West London Pathology, London, UK.
⁵ Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; North West London Pathology, London, UK.

Comment

Scott J C Pallett et al. Lancet Respir Med. 2020 Oct.

. 2020 Oct;8(10):e74.

doi: 10.1016/S2213-2600(20)30406-9. Epub 2020 Sep 14.

¹ Centre of Defence Pathology, Royal Centre for Defence Medicine, Queen Elizabeth Hospital Birmingham, Birmingham B15 2WB, UK; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK. Electronic address: scott.pallett@nhs.net.
² Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
³ NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
⁴ Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; North West London Pathology, London, UK.
⁵ Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; North West London Pathology, London, UK.

No abstract available

Comment on

Serological assays for delayed SARS-CoV-2 case identification.
Choy KW. Choy KW. Lancet Respir Med. 2020 Oct;8(10):e73. doi: 10.1016/S2213-2600(20)30409-4. Epub 2020 Sep 14. Lancet Respir Med. 2020. PMID: 32941850 Free PMC article. No abstract available.
Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study.
Mesnier J, Cottin Y, Coste P, Ferrari E, Schiele F, Lemesle G, Thuaire C, Angoulvant D, Cayla G, Bouleti C, Gallet de Saint Aurin R, Goube P, Lhermusier T, Dillinger JG, Paganelli F, Saib A, Prunier F, Vanzetto G, Dubreuil O, Puymirat E, Boccara F, Eltchaninoff H, Cachanado M, Rousseau A, Drouet E, Steg PG, Simon T, Danchin N. Mesnier J, et al. Lancet Public Health. 2020 Oct;5(10):e536-e542. doi: 10.1016/S2468-2667(20)30188-2. Epub 2020 Sep 18. Lancet Public Health. 2020. PMID: 32950075 Free PMC article.

1. Pallett SJC, Rayment M, Patel A. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2020;8:885–894. - PMC - PubMed
1. Wang YS, Shen H, Sun SH. Analysis of false-positive associated with antibody tests for SARS-CoV in SLE patients. Shi Yan Sheng Wu Xue Bao. 2003;36:314–317. (in Chinese). - PubMed
1. Chen Y, Li L. SARS-CoV-2: virus dynamics and host response. Lancet Infect Dis. 2020;20:515–516. - PMC - PubMed
1. Public Health England Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. August 18, 2020. https://www.gov.uk/government/publications/guidance-on-shielding-and-pro...
1. Flower B, Brown JC, Simmons B. Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey. Thorax. 2020 doi: 10.1136/thoraxjnl-2020-215732. published online Aug 12. - DOI - PMC - PubMed